On the Brink of Change
White Paper
Nov 20, 2018
How Academic Data and Machine Learning Can Revolutionize Alzheimer's Drug Development

In this white paper, you will:

  • Hear about current industry challenges in Alzheimer’s drug development and glean insights as to why we must explore new clinical approaches
  • Understand the importance of machine learning and predictive analytics for identifying non-diagnosed prodromal Alzheimer’s disease patients—and why we must tap into this unexplored general population to bring about real advancement
  • Learn why innovative approaches to Alzheimer’s drug development are not only necessary, but how they will positively impact the future of Alzheimer’s disease for patients and the medical community alike
Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.